{
    "id": "chatcmpl-6znElLD5L4YsSrdfvtPknJSzBCofv",
    "object": "chat.completion",
    "created": 1680185295,
    "model": "gpt-3.5-turbo-0301",
    "usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 808,
        "total_tokens": 2135
    },
    "choices": [
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. Dobutamine is a positive inotrope that increases cardiac contractility and stroke volume, thus increasing myocardial oxygen consumption. It does not affect atrioventricular conduction velocities, and it may cause some degree of vasodilation due to beta-2 receptor activity, which would lead to decreased systemic vascular resistance."
            },
            "finish_reason": "stop",
            "index": 0
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. Dobutamine is a sympathomimetic drug that stimulates beta-1 receptors in the heart, resulting in increased cardiac contractility and heart rate, which can increase myocardial oxygen consumption. It does not affect atrioventricular conduction velocities or cause systemic vasoconstriction. It actually decreases systemic vascular resistance by dilating blood vessels. Therefore, option (B) is the correct answer."
            },
            "finish_reason": "stop",
            "index": 1
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. Dobutamine is a medication that increases cardiac output by increasing myocardial contractility. As a result of this therapy, there will be an increase in myocardial oxygen consumption. A slowed AV conduction would be a negative effect on the heart, and dobutamine would not cause systemic vasoconstriction, but rather vasodilation. Decreased cardiac contractility would be a negative effect of therapy, which is not the intended result."
            },
            "finish_reason": "stop",
            "index": 2
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. Dobutamine is a sympathomimetic drug that acts on beta-1 adrenergic receptors to increase cardiac contractility, heart rate, and myocardial oxygen consumption. It does not affect atrioventricular conduction velocities and does not cause systemic vasoconstriction. Therefore, the correct answer is (B)."
            },
            "finish_reason": "stop",
            "index": 3
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. Dobutamine is a beta-1 agonist which increases cardiac contractility, stroke volume and cardiac output, ultimately leading to decreased heart failure symptoms. However, this increase in contractility also increases myocardial oxygen consumption. Slowed atrioventricular conduction velocities and increased systemic vascular resistance due to systemic vasoconstriction are not effects of dobutamine therapy."
            },
            "finish_reason": "stop",
            "index": 4
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. Dobutamine is a beta-1 agonist, so the most likely effect is increased myocardial oxygen consumption due to increased contractility. It also has some vasodilating effects, which would decrease systemic vascular resistance rather than increase it, and it would not slow atrioventricular conduction velocities or decrease cardiac contractility."
            },
            "finish_reason": "stop",
            "index": 5
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. Dobutamine is a medication that is used to improve symptoms of heart failure by increasing cardiac contractility and cardiac output. It does not affect atrioventricular conduction velocities or systemic vascular resistance, and actually produces systemic vasodilation. However, increased myocardial oxygen consumption is a potential side effect of dobutamine therapy."
            },
            "finish_reason": "stop",
            "index": 6
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. Dobutamine is a sympathomimetic drug that stimulates beta-1 adrenergic receptors in the heart, leading to increased cardiac output and myocardial oxygen consumption. It does not affect atrioventricular conduction velocities or systemic vascular resistance, and it actually increases cardiac contractility. Therefore, the correct answer is (B) Increased myocardial oxygen consumption."
            },
            "finish_reason": "stop",
            "index": 7
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. Dobutamine is a medication used to increase cardiac output in congestive heart failure patients. It does not slow atrioventricular conduction velocities and does not increase systemic vascular resistance. Rather, it increases myocardial oxygen consumption and cardiac contractility, which helps alleviate symptoms of congestive heart failure."
            },
            "finish_reason": "stop",
            "index": 8
        },
        {
            "message": {
                "role": "assistant",
                "content": "We refer to Wikipedia articles on medicine for help. Dobutamine is a beta-1 adrenergic agonist that increases cardiac contractility and heart rate, leading to an increase in myocardial oxygen consumption. It may also cause vasodilation and a decrease in systemic vascular resistance. Slowed AV conduction velocities and decreased cardiac contractility are not expected effects of dobutamine."
            },
            "finish_reason": "stop",
            "index": 9
        }
    ]
}